Cargando…
Recrudescence of severe polyneuropathy after receiving Pfizer-BioNTech COVID-19 vaccine in a patient with a history of eosinophilic granulomatosis with polyangiitis
A middle age man with a history of diabetes mellitus type 2, hypertension, migraine and eosinophilic granulomatosis with polyangiitis (EGPA) with polyneuropathy in remission presented with paresthesia and motor weakness soon after receiving the Pfizer-BioNTech COVID-19 messanger RNA (mRNA) vaccine....
Autores principales: | Gill, Rahul, Rizvi, Macym, Sadiq, Muhammad S, Feldman, Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9058677/ https://www.ncbi.nlm.nih.gov/pubmed/35487626 http://dx.doi.org/10.1136/bcr-2021-245749 |
Ejemplares similares
-
Prolonged angioedema after Pfizer-BioNTech COVID-19 vaccine
por: Muhamad Fauzi, Siti Mardhiah
Publicado: (2023) -
Venous sinus thrombosis after the first dose of Pfizer BioNTech vaccine
por: Qureshi, Muhammad Imran Ahmad, et al.
Publicado: (2022) -
Cerebellar and brainstem stroke possibly associated with booster dose of BNT162b2 (Pfizer-BioNTech) COVID-19 vaccine
por: Thomas, Michael George, et al.
Publicado: (2023) -
COVID-19-Vaccine-Pfizer-BioNTech: Eosinophilic granulomatosis with polyangiitis relapse: case report
Publicado: (2022) -
Concurrent facial and trigeminal nerve palsies in a child following COVID-19 vaccination with the Pfizer vaccine
por: Moezinia, Carine, et al.
Publicado: (2023)